CLINICAL_TRIALS
research
· 2017-07-18
Clinical Trial Update: Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients [Phase 2]
Summary
This document describes a Phase 2 trial protocol to prevent lamotrigine-induced skin rash in patients with epilepsy. The study is being developed by Seoul Natio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Lamotrigine Allergy | Phase 2 | Status: UNKNOWN